InvestorsHub Logo
Followers 4
Posts 1195
Boards Moderated 0
Alias Born 10/03/2015

Re: None

Sunday, 06/05/2016 12:39:15 PM

Sunday, June 05, 2016 12:39:15 PM

Post# of 977
Written by AF:

Experimental drugs with the FDA imprimatur of Breakthrough Therapy status are not guaranteed to succeed. The list of failed Breakthrough Therapy drugs is surprisingly long and includes Biomarin's drisapersen, Aduro Biotech's CRS-2017, Celladon's Mydicar and the aforementioned rindopepimut from Celldex.

https://www.thestreet.com/story/13594991/1/immunomedics-kicked-out-of-prestigious-asco-cancer-conference.html?puc=yahoo&cm_ven=YAHOO